These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18230836

  • 1. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [Abstract] [Full Text] [Related]

  • 2. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y.
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [Abstract] [Full Text] [Related]

  • 3. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N.
    BMC Musculoskelet Disord; 2017 Feb 13; 18(1):79. PubMed ID: 28193220
    [Abstract] [Full Text] [Related]

  • 4. Tumour-induced osteomalacia.
    Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT.
    Nat Rev Dis Primers; 2017 Jul 13; 3():17044. PubMed ID: 28703220
    [Abstract] [Full Text] [Related]

  • 5. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
    de Jongh RT, Vervloet MG, Bravenboer N, Heijboer AC, den Heijer M, Lips P.
    Ned Tijdschr Geneeskd; 2013 Jul 13; 157(28):A5908. PubMed ID: 23841927
    [Abstract] [Full Text] [Related]

  • 6. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L, Padala SA, Mohammed A, Belayneh N.
    J Investig Med High Impact Case Rep; 2019 Jul 13; 7():2324709619895162. PubMed ID: 31850815
    [Abstract] [Full Text] [Related]

  • 7. Challenging case of tumour-induced osteomalacia.
    Kumar P, Jadhav DV, Ravat SH, Jain N.
    BMJ Case Rep; 2022 May 19; 15(5):. PubMed ID: 35589273
    [Abstract] [Full Text] [Related]

  • 8. Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy.
    Ovejero D, El-Maouche D, Brillante BA, Khosravi A, Gafni RI, Collins MT.
    J Bone Miner Res; 2017 Aug 19; 32(8):1667-1671. PubMed ID: 28459498
    [Abstract] [Full Text] [Related]

  • 9. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G, Varsavsky M.
    Endocrinol Nutr; 2016 Apr 19; 63(4):181-6. PubMed ID: 26718193
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R, Ares O, Sierra J, Pérez-Dominguez M.
    Arch Orthop Trauma Surg; 2009 Apr 19; 129(4):533-9. PubMed ID: 19125258
    [Abstract] [Full Text] [Related]

  • 11. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.
    Higley M, Beckett B, Schmahmann S, Dacey E, Foss E.
    Skeletal Radiol; 2015 Dec 19; 44(12):1825-31. PubMed ID: 26341245
    [Abstract] [Full Text] [Related]

  • 12. Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?
    Latifyan SB, Vanhaeverbeek M, Klastersky J.
    BMJ Case Rep; 2014 Nov 17; 2014():. PubMed ID: 25406200
    [Abstract] [Full Text] [Related]

  • 13. Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report.
    Igney-Oertel A, Artunc F, Henes J, Hoffmann R, Clasen S.
    Joint Bone Spine; 2016 Oct 17; 83(5):603-4. PubMed ID: 27006265
    [No Abstract] [Full Text] [Related]

  • 14. Lymphatic vessels are present in phosphaturic mesenchymal tumours.
    Williams K, Flanagan A, Folpe A, Thakker R, Athanasou NA.
    Virchows Arch; 2007 Nov 17; 451(5):871-5. PubMed ID: 17674036
    [Abstract] [Full Text] [Related]

  • 15. Tumor-induced osteomalacia: experience from a South American academic center.
    González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P, Contreras O, Villa A, Salech F, Toro L, Michea L, Florenzano P.
    Osteoporos Int; 2017 Jul 17; 28(7):2187-2193. PubMed ID: 28341900
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
    Garg B, Mehta N, Goyal A, Khadgawat R.
    BMJ Case Rep; 2020 Dec 16; 13(12):. PubMed ID: 33328210
    [Abstract] [Full Text] [Related]

  • 17. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
    Nasu T, Kurisu S, Matsuno S, Tatsumi K, Kakimoto T, Kobayashi M, Nakano Y, Wakasaki H, Furuta H, Nishi M, Sasaki H, Suzuki H, Ito N, Fukumoto S, Nanjo K.
    Intern Med; 2008 Dec 16; 47(10):957-61. PubMed ID: 18480582
    [Abstract] [Full Text] [Related]

  • 18. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
    Elderman JH, Wabbijn M, de Jongh F.
    BMJ Case Rep; 2016 Apr 26; 2016():. PubMed ID: 27118742
    [Abstract] [Full Text] [Related]

  • 19. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
    Hoshino C, Satoh N, Sugawara S, Kuriyama C, Kikuchi A, Ohta M.
    Intern Med; 2008 Apr 26; 47(5):453-7. PubMed ID: 18310982
    [Abstract] [Full Text] [Related]

  • 20. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
    Vollmer S, Olsson K.
    BMJ Case Rep; 2024 May 02; 17(5):. PubMed ID: 38697682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.